Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Found a similar drug application it took 10 mths.

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Feb 01, 2022 4:36pm

180 Views

Post# 34386892

Found a similar drug application it took 10 mths.

Palonosetron hydrochloride	Antiemetics and antinauseants	215829	2018-06	2019-04

Application june 2018 approved April 2019 above but that was pre covid so who knows and there are 25 applications submitted waiting for approval before Tetras Dronabinol submitted in May 2021.

Palonosetron, sold under the brand name Aloxi, is used for the prevention and treatment of chemotherapy-induced nausea and vomiting

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program